TechNet-21 - Forum

This forum provides a place for members to ask questions, share experiences, coordinate activities, and discuss recent developments in immunization.

Discussions tagged Immunization information systems

Polio resurgence

Last Friday (Dec 6), The Star reported the country’s Health Ministry confirming that a three-month-old boy from Tuaran, Sabah, has been infected with vaccine-derived poliovirus type 1 (VDPV1) after being admitted into a hospital’s intensive care unit. The Star quoted health director-general Dr Noor Hisham Abdullah who said on Sunday (Dec 8): “The patient is currently undergoing treatment in an isolation ward and is in stable condition but needs respiratory support.” He added that the poliovirus is classified as a circulating vaccine-derived poliovirus type 1 (VDPV1), which originates from a poliovirus that has been weakened by the orally-administered polio vaccine. The Star reported that Dr Hisham said the weakened virus excretes from the body through faeces. However, in unsanitary environments, the virus can infect others who have not been immunised against polio and will “thus spread in communities whose polio immunisation rates are less than 95 per cent”. He warned that if the disease is left uncontrolled, it can genetically mutate until it once again becomes an active virus. In an article on Monday (Dec 9), The Associated Press (AP) quoted Dr Hisham as saying that vaccination will be stepped up after an investigation in the infant’s home village showed that 25 out of 204 children, aged between two months and 15 years, were not vaccinated against polio.
Link: https://www.businessinsider.my/malaysias-first-polio-case-in-27-years-is-a-child-who-wasnt-vaccinated-here-are-3-things-to-know-about-the-incurable-virus/

Join us on Thursday! Webinar: Five proven strategies to improve immunization data use

Join us for a webinar: Five proven strategies to improve immunization data use (Findings from the Immunization Data: Evidence for Action Review) Date: Thursday, December 5, 2019 3:00 pm
Europe Time (Paris, GMT+01:00) The use of high-quality data is widely understood in the global health community to be a cornerstone of well-functioning health systems. However, despite continuous growth in the amount of health data available, the actual use of data in immunization program decision-making remains a challenge. Part of the challenge has been a limited understanding of what tools and approaches actually are effective in increasing the use of immunization data to support improvements in vaccine delivery and access. The Immunization Data: Evidence for Action (IDEA) Review was undertaken to identify the existing evidence on what works to improve the use of immunization data, and to synthesize that evidence into actionable steps that implementers, policymakers and funders can take to design better data use interventions.

During this webinar, the presenters from PATH will share the methodology used to identify and review 549 pieces of evidence and five proven strategies to improve data use that were uncovered. They also will discuss the evidence gap map that was developed and how the global immunization community can work together to increase the quality of evidence available on best practices for data use to help further the work started by the IDEA team.


Discussion panelists

Laurie Werner- Director of Program, Center of Digital and Data Excellence, PATH
Allison Osterman- Program Officer, Health Systems Innovation and Delivery, PATH

Save the date and please join us! Link to register: https://who-meeting.webex.com/who-meeting/onstage/g.php?MTID=ec0039a66d95132ed3f30c6988ade4314

Is it time to explore a different way of looking at immunization coverage and system strength?

A recent article in Science authored by Michael Mina and colleagues concludes that measles infection reduces antibodies that provide protection against infections thereby reducing the benefits of prior vaccination (https://science.sciencemag.org/content/366/6465/599). Measles vaccination acts as an essential complement to other vaccines; hence, defining system strength by DTP3 or MCV1 coverage appears inadequate. Because coverage can also be seen as a probability, it is possible to multiply DTP3 and MCV1 coverage to obtain the probability that an infant has received both. With this joint coverage approach, there is still a reassuringly high number of countries where coverage exceeds 90%. However, not surprisingly, there are about twice as many countries with coverage less than 70% using the joint methodology than through the use of either DTP3 or MCV1. The use of a joint coverage approach may be better at identifying weaknesses and fragility in immunization systems.

Discussion: The IDEAL-Vietnam project would like global feedback and collaboration on the topic of, “Partnering with Mobile Network Operators for electronic immunization registry application”, after the release of the project’s first case study.

The PATH, Introducing Digital immunization information systems- Exchange and Learning (IDEAL) project, funded by the Bill & Melinda Gates Foundation is excited to release the first lessons learned on transitioning from a paper-based immunization registry to an entirely digital system. The case study reflects necessary partnerships in the development and scale-up of current electronic immunization registry (EIR) in Vietnam, the National Immunization Information System (NIIS). The study describes the benefits and challenges of partnerships between the Ministry of Health, PATH and Mobile Network Operator (Viettel). Both local governments, partnering NGOs and Mobile Network Operators play a vital role in the application of a software-based immunization registry, but as Vietnam’s story demonstrates there is both critical advanced planning and necessary steps to ensure these partnerships are as strong and sustainable as possible, maximizing both resources and time to increase health benefits. The study discusses the development of partnerships that enabled the successful scale-up of Vietnam’s NIIS from a pilot project to a nation-wide application. The World Health Organizations, “A practical guide for engaging with mobile network operators in Health for reproductive, maternal, newborn and child health” was used as a comparative guide in the case study, to relate Vietnam’s experience to existing EIR global resources. The case study highlights the benefits of key partnerships in EIR implementation and drivers for cultivating partnerships from both MNO and MOH perspectives. The report also demonstrates the hurdles that Vietnam experienced, demonstrating when possible, how Vietnam was able to overcome the challenges as the country continues to transition to an entirely digital immunization registry. The first lesson learned case study also serves as a gateway to introduce IDEAL’s new homepage on TechNet-21, where you can find all IDEAL- project reports, announcements and materials in English and Vietnamese. Over the course of the next two years IDEAL-project will explore more lessons learned from Vietnam in the process of moving to completely digital, each zoning-in on an important aspect of the electronic immunization registry process.   IDEAL-Vietnam project would like your feedback on the first case study and first topic of our lessons learned library, “Partnering with Mobile Network Operators”: 1.) What has been some of your countries/organization’s key challenges in the identification, formation, or maintenance of a partnership with a MNO?   2.) What lessons learned or take-away message did you find most valuable for our case study?   3.) What are some lessons learned or take-away messages you think are important to share from your country/organizations experience/partnerships?   4.) What are some other global guidance documents your country/organization have used to determine best practice for forming necessary partnerships for the EIR application?   5.) What aspects from the Vietnam perspective can your own country/organization relate to in regard to the partnerships formed for EIR application? What aspects are less relatable?   6.) If the IDEAL-project could expand/revise this case study in the future what areas would be most helpful to detail further?  
  • Page :
  • 1